Since listing, MedLife has completed one of the most extensive expansion programmes in the Romanian private sector, consolidating over 60 acquisitions and developing an integrated medical platform nationwide. The company has invested consistently in technology, AI, robotics, drones and medical equipment, contributing to increased access to modern healthcare services for millions of patients.
"Reaching the €1 billion capitalisation threshold is an important validation for us and proof that the MedLife model remains solid and relevant, regardless of context," said Mihai Marcu, President and CEO of MedLife Group. "We remain focused on investments in innovation and medical research: genomics, artificial intelligence - especially in imaging and laboratory, developing prevention programmes and continuing personalised medicine projects."
The network expansion includes over 450 owned medical units and more than 60 M&A transactions, creating Romania's first integrated medical ecosystem covering prevention, laboratory, outpatient, hospital, imaging and occupational medicine services. Revenue increased from RON 502 million in 2016 to RON 2.72 billion in 2024, while EBITDA grew from RON 70 million to RON 416 million pro-forma.
